Try our beta test site
455 studies found for:    Open Studies | "Hormones"
Show Display Options
Rank Status Study
1 Not yet recruiting Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment
Condition: Growth Hormone Treatment
Intervention: Behavioral: Play Back Sessions
2 Recruiting A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Condition: Metastatic Hormone Sensitive Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo
3 Recruiting Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: PEG-somatropin
4 Recruiting Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Biological: Jintropin AQ
5 Recruiting Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children
Condition: Pediatric Growth Hormone Deficiency
Interventions: Drug: MOD-4023;   Drug: Somatropin
6 Recruiting A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Adult Growth Hormone Deficiency
Interventions: Drug: somapacitan;   Drug: Norditropin
7 Recruiting Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: Norditropin® FlexPro® pen
8 Recruiting A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Condition: Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Interventions: Drug: LEE011;   Drug: Letrozole;   Drug: Tamoxifen;   Drug: Fulvestrant;   Drug: goserelin
9 Not yet recruiting A Phase 1, First-in-Human, Multi-Part Study of RAD140 in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Intervention: Drug: RAD140
10 Recruiting Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients
Conditions: Burns;   Growth Hormone Treatment
Interventions: Drug: Somatropin;   Drug: 0.09% Saline Solution
11 Recruiting Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
Conditions: Ductal Infiltrating Metastatic Breast Cancer;   Hormone-receptors Positive Breast Cancer
Intervention: Biological: Circulating tumor cells counting at baseline
12 Recruiting Impact of Recombinant Human Growth Hormone on HIV Persistence
Conditions: Human Immunodeficiency Virus;   Growth Hormone Treatment
Intervention: Drug: Somatotropin (Human)
13 Recruiting Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
Conditions: Early-Stage Breast Carcinoma;   Hormone Receptor Positive Tumor
Interventions: Drug: Tamoxifen or Aromatase Inhibitor or Aromatase Inhibitor + goserelin;   Drug: Palbociclib
14 Recruiting Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)
Conditions: Pediatric Growth Hormone Deficiency;   Growth Disorders
Intervention: Drug: Somavaratan (VRS-317)
15 Recruiting Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
Condition: Growth Hormone Deficiency
Intervention: Biological: PEG-somatropin
16 Not yet recruiting Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy
Conditions: IGHD - Isolated Growth Hormone Deficiency;   Growth Retardation
Interventions: Dietary Supplement: Nutritional supplementation standardized formula;   Dietary Supplement: Placebo
17 Recruiting A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients
Condition: Growth Hormone Deficiency
Intervention: Other: Non Interventional Study
18 Recruiting Versartis Long-Term Safety Study of Somavaratan
Condition: Pediatric Growth Hormone Deficiency
Intervention: Drug: somavaratan
19 Recruiting Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in AGHD
Condition: Adult Growth Hormone Deficiency (AGHD)
Intervention: Drug: somavaratan
20 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature;   Growth Hormone Deficiency
Interventions: Drug: Niacin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.